{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:32:19Z","timestamp":1794281539828,"version":"4.9.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK134408"],"award-info":[{"award-number":["R01DK134408"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL089221"],"award-info":[{"award-number":["R01HL089221"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL143612"],"award-info":[{"award-number":["R01HL143612"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R01EB034573"],"award-info":[{"award-number":["R01EB034573"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD09486"],"award-info":[{"award-number":["R01HD09486"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xcrm.2025.102475","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:16:53Z","timestamp":1764173813000},"page":"102475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Complete neutralizing antibody evasion by serodivergent non-mammalian AAVs enables gene therapy redosing"],"prefix":"10.1016","volume":"6","author":[{"given":"Ezra J.","family":"Loeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia M.","family":"Fergione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Yudistyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco M.","family":"Fanous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail R.","family":"Benkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delaney G.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai K.","family":"ElMallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5563-4877","authenticated-orcid":false,"given":"Aravind","family":"Asokan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102475_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102475_bib2","series-title":"Fields Virology","first-page":"1768","article-title":"Parvoviridae","author":"Berns","year":"2013"},{"key":"10.1016\/j.xcrm.2025.102475_bib3","doi-asserted-by":"crossref","first-page":"D708","DOI":"10.1093\/nar\/gkx932","article-title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)","volume":"46","author":"Lefkowitz","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102475_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veaa043","article-title":"Evolution of dependoparvoviruses across geological timescales\u2014implications for design of AAV-based gene therapy vectors","volume":"6","author":"Hildebrandt","year":"2020","journal-title":"Virus Evol."},{"key":"10.1016\/j.xcrm.2025.102475_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1001263","article-title":"rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102475_bib6","article-title":"Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings","volume":"8","author":"Au","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.xcrm.2025.102475_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00341","article-title":"Humoral Immune Response to AAV","volume":"4","author":"Calcedo","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102475_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2021.287","article-title":"Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A","volume":"33","author":"Klamroth","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2025.102475_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101273","article-title":"Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies","volume":"32","author":"Chhabra","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2025.102475_bib10","doi-asserted-by":"crossref","first-page":"15941","DOI":"10.1038\/s41598-024-66546-4","article-title":"Seroprevalence of adeno-associated virus types 1, 2, 3, 4, 5, 6, 8, and 9 in a Basque cohort of healthy donors","volume":"14","author":"Navarro-Oliveros","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102475_bib11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.7150\/thno.89380","article-title":"Understanding AAV vector immunogenicity: from particle to patient","volume":"14","author":"Dhungel","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2025.102475_bib12","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.ymthe.2020.06.001","article-title":"Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B","volume":"28","author":"George","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102475_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00670","article-title":"Human Immune Responses to Adeno-Associated Virus (AAV) Vectors","volume":"11","author":"Ronzitti","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102475_bib14","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","article-title":"Lethal immunotoxicity in high-dose systemic AAV therapy","volume":"31","author":"Duan","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102475_bib15","doi-asserted-by":"crossref","first-page":"e0033522","DOI":"10.1128\/jvi.00335-22","article-title":"Characterization of the Serpentine Adeno-Associated Virus (SAAV) Capsid Structure: Receptor Interactions and Antigenicity","volume":"96","author":"Mietzsch","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102475_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00780-23","article-title":"Structural and antigenic characterization of the avian adeno-associated virus capsid","volume":"97","author":"Hsi","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102475_bib17","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1128\/JVI.77.12.6799-6810.2003","article-title":"Cloning of an Avian Adeno-Associated Virus (AAAV) and Generation of Recombinant AAAV Particles","volume":"77","author":"Bossis","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102475_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113902","article-title":"Capsid-mediated control of adeno-associated viral transcription determines host range","volume":"43","author":"Loeb","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102475_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/v11040362","article-title":"Twenty-Five Years of Structural Parvovirology","volume":"11","author":"Mietzsch","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2025.102475_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature16465","article-title":"An essential receptor for adeno-associated virus infection","volume":"530","author":"Pillay","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102475_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/gt.2016.75","article-title":"Direct Interaction of Human Serum Proteins with AAV Virions to Enhance AAV Transduction: Immediate Impact on Clinical Applications","volume":"24","author":"Wang","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2025.102475_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymeth.2015.10.004","article-title":"Gene therapy in monogenic congenital myopathies","volume":"99","author":"Guan","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.xcrm.2025.102475_bib23","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1038\/s41467-020-19230-w","article-title":"Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants","volume":"11","author":"Weinmann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102475_bib24","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102475_bib25","doi-asserted-by":"crossref","first-page":"7965","DOI":"10.1038\/s41467-024-52002-4","article-title":"An engineered AAV targeting integrin alpha V beta 6 presents improved myotropism across species","volume":"15","author":"Vu Hong","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102475_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpeds.2021.12.072","article-title":"Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening","volume":"244","author":"Lee","year":"2022","journal-title":"J. Pediatr."},{"key":"10.1016\/j.xcrm.2025.102475_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/humc.2015.068","article-title":"Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning","volume":"26","author":"Corti","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.xcrm.2025.102475_bib28","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1016\/j.ymthe.2022.11.001","article-title":"Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells","volume":"30","author":"Handyside","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102475_bib29","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ymthe.2022.03.004","article-title":"Durability of transgene expression after rAAV gene therapy","volume":"30","author":"Muhuri","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102475_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02213-17","article-title":"An Alternate Route for Adeno-associated Virus (AAV) Entry Independent of AAV Receptor","volume":"92","author":"Dudek","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102475_bib31","series-title":"Dynamics of Immune Activation in Viral Diseases","first-page":"9","article-title":"Antibody-Dependent Enhancement of Viral Infections","author":"Kulkarni","year":"2020"},{"key":"10.1016\/j.xcrm.2025.102475_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2011.00194","article-title":"Innate immune responses to AAV vectors","volume":"2","author":"Rogers","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2025.102475_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3505","article-title":"Successful liver transduction by re-administration of different adeno-associated virus vector serotypes in mice","volume":"25","author":"Baatartsogt","year":"2023","journal-title":"J. Gene Med."},{"key":"10.1016\/j.xcrm.2025.102475_bib34","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.ymthe.2017.05.003","article-title":"Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5ch and AAV1","volume":"25","author":"Majowicz","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2025.102475_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/v16010057","article-title":"AAV Vectors Pseudotyped with Capsids from Porcine and Bovine Species Mediate In Vitro and In Vivo Gene Delivery","volume":"16","author":"Yu","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2025.102475_bib36","doi-asserted-by":"crossref","first-page":"E4812","DOI":"10.1073\/pnas.1704766114","article-title":"Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion","volume":"114","author":"Tse","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102475_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00976-20","article-title":"Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach","volume":"94","author":"Havlik","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102475_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00441","article-title":"Optimized AAV rh.10 vectors that partially evade neutralizing antibodies during hepatic gene transfer","volume":"8","author":"Selot","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102475_bib39","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1038\/s41467-025-59088-4","article-title":"Structural characterization of antibody-responses following Zolgensma treatment for AAV capsid engineering to expand patient cohorts","volume":"16","author":"Mietzsch","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102475_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41551-023-01129-8","article-title":"Rational immunosilencing of a promiscuous T-cell epitope in the capsid of an adeno-associated virus","volume":"8","author":"Bing","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102475_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.29","article-title":"AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes","volume":"2","author":"Hui","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2025.102475_bib42","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2008-07-167510","article-title":"AAV-1\u2013mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells","volume":"114","author":"Mingozzi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102475_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212136","article-title":"The HLA class I immunopeptidomes of AAV capsid proteins","volume":"14","author":"Brito-Sierra","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102475_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1067399","article-title":"The HLA class-II immunopeptidomes of AAV capsids proteins","volume":"13","author":"Brito-Sierra","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102475_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.ai.2016.05.001","article-title":"The Roles of the Secreted Phospholipase A2 Gene Family in Immunology","volume":"132","author":"Murakami","year":"2016","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.xcrm.2025.102475_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00799-25","article-title":"Functional orthogonality of parvoviral phospholipase A2 domains in adeno-associated virus transduction","volume":"99","author":"Hull","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102475_bib47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.omtm.2019.01.008","article-title":"Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors","volume":"12","author":"B\u00fcning","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2025.102475_bib48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41591-024-03304-z","article-title":"AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial","volume":"31","author":"Mendell","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102475_bib49","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-022-33745-4","article-title":"Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing","volume":"13","author":"Gonzalez","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102475_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2105-5-113","article-title":"MUSCLE: A multiple sequence alignment method with reduced time and space complexity","volume":"5","author":"Edgar","year":"2004","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2025.102475_bib51","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.xcrm.2025.102475_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102475_bib53","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.xcrm.2025.102475_bib54","doi-asserted-by":"crossref","first-page":"W110","DOI":"10.1093\/nar\/gkaf422","article-title":"CapBuild: a cloud-native tool for adeno-associated virus capsid engineering","volume":"53","author":"Klein","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102475_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00843-21","article-title":"Adeno-associated Virus 9 Structural Rearrangements Induced by Endosomal Trafficking pH and Glycan Attachment","volume":"95","author":"Penzes","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2025.102475_bib56","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2025.102475_bib57","first-page":"450","article-title":"A fluorometric assay of alpha-glucosidase and its application in the study of Pompe\u2019s disease","volume":"81","author":"Salafsky","year":"1973","journal-title":"J. Lab. Clin. Med."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125005488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125005488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:50:26Z","timestamp":1790265026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125005488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2666379125005488"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102475","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete neutralizing antibody evasion by serodivergent non-mammalian AAVs enables gene therapy redosing","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102475"}}